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Reelin Is a Ligand for Lipoprotein Receptors
cerebellum, that lead to the formation of cell layers andGabriella D'Arcangelo, Ramin Homayouni,
Lakhu Keshvara, Dennis S. Rice, the growth of neuronal processes (D'Arcangelo and Cur-
ran, 1998).Michael Sheldon, and Tom Curran*
Department of Developmental Neurobiology A mutant phenotype identical to that observed in
reeler has also been described in mice carrying muta-St. Jude Children's Research Hospital
332 N. Lauderdale tions in the disabled-1 (dab1) gene (Howell et al., 1997b;
Sheldon et al., 1997). Dab1 is an intracellular adapterMemphis, Tennessee 38105
protein that is expressed in Reelin target cells (Howell
et al., 1997a; Rice et al., 1998). Dab1 accumulates in the
absence of Reelin, suggesting that Reelin may promoteSummary
degradation of Dab1 (Sheldon et al., 1997; Rice et al.,
1998). The addition of Reelin to primary neuronal cul-A signaling pathway involving the extracellular protein
Reelin and the intracellular adaptor protein Disabled-1 tures results in increased tyrosine phosphorylation of
Dab1 (Howell et al., 1999a). Thus, Dab1 is thought to(Dab1) controls cell positioning during mammalian
brain development. Here, we demonstrate that Reelin function downstream of Reelin in a signal transduction
cascade that controls appropriate cell positioning in thebinds directly to lipoprotein receptors, preferably the
very low-density lipoprotein receptor (VLDLR) and developing brain.
Recently, reeler-like defects were described in miceapolipoprotein E receptor 2 (ApoER2). Binding re-
quires calcium, and it is inhibited in the presence of lacking two members of the low-density lipoprotein re-
ceptor (LDLR) family, the very low-density lipoproteinapoE. Furthermore, the CR-50 monoclonal antibody,
which inhibits Reelin function, blocks the association receptor (VLDLR) and the apolipoprotein E receptor 2
(ApoER2) (Trommsdorff et al., 1999). These mice areof Reelin with VLDLR. After binding to VLDLR on the
cell surface, Reelin is internalized into vesicles. In dis- ataxic, and they exhibit cerebellar hypoplasia and ab-
normal cortical lamination. Mutation of VLDLR andsociated neurons, apoE reduces the level of Reelin-
induced tyrosine phosphorylation of Dab1. These data ApoER2 individually results in subtle defects in cell posi-
tioning and reduced dendritic arborization (Trommsdorffsuggest that Reelin directs neuronal migration by
binding to VLDLR and ApoER2. et al., 1999). In mammals, the LDLR family comprises five
members, LDLR, LDLR-related protein (LRP), Megalin,
VLDLR, and ApoER2 (Gliemann, 1998). LDLR functions
in the systemic clearance of lipoproteins and in the regu-Introduction
lation of lipid transport and metabolism (Brown and
Goldstein, 1986). In egg-laying species, related recep-The investigation of spontaneous and targeted muta-
tors also mediate the uptake of yolk constituents bytions in mice has led to the identification of a number
oocytes (Schneider, 1995). The functions of the mamma-of genes that are required for appropriate neuronal posi-
lian genes related to LDLR are less well defined. Alltioning in developing brain structures. In particular, dis-
members of this family bind apolipoprotein E (apoE)-ruption of the reelin gene (D'Arcangelo et al., 1995)
containing lipoproteins. In addition, VLDLR, LRP, andcauses the classic neurological mutation reeler, which
Megalin bind and internalize a variety of extracellularis characterized by ataxia, tremors, imbalance, and a
ligands including proteases, protease inhibitors, peptidereeling gait that becomes apparent 2 weeks after birth
hormones, and vitamin carrier proteins (Gliemann,(D'Arcangelo and Curran, 1998; Lambert de Rouvroit
1998). VLDLR (Takahashi et al., 1992) has also beenand Goffinet, 1998). These behavioral defects are asso-
referred to as LR8 (LDLR-related protein with eight li-ciated with severe hypoplasia of the cerebellum and
gand-binding repeats) to emphasize the fact that itsneuronal ectopia in laminated brain regions, including
affinity for VLDL is low and that other higher affinitythe cerebral and cerebellar cortices and the hippocam-
ligands for this receptor may exist (Nimpf and Schneider,pus. reelin mRNA encodes a large extracellular glyco-
1998). Similarly, ApoER2 has also been referred to asprotein containing eight repeated sequences that in-
LR7/8B (LDLR-related protein with seven or eight ligandclude EGF-like cysteine motifs (D'Arcangelo et al., 1995,
repeats that is expressed in the brain) (Kim et al., 1996;1997). During embryonic development, reelin is ex-
pressed by neuronal populations that occupy the most Nimpf and Schneider, 1998). VLDLR and ApoER2 are the
superficial layers of the brain (D'Arcangelo et al., 1995; most closely related genes among the family members,
Ogawa et al., 1995; Rice et al., 1998). These include suggesting that they may have overlapping functions.
Cajal Retzius cells in the neocortex and hippocampus They are expressed at relatively high levels throughout
and cells in the external germinal layer of the cerebellum. the brain, including the developing regions affected by
Reelin is thought to direct layer formation by eliciting Reelin (Kim et al., 1996; Trommsdorff et al., 1999). VLDLR
responses in target neurons, such as cortical plate neu- and ApoER2 are present in the cortical plate and in
rons in the cerebral cortex and Purkinje cells in the the developing hippocampus during embryogenesis
(Trommsdorff et al., 1999). These cell populations ex-
press Dab1, and they respond to Reelin that is secreted* To whom correspondence should be addressed (e-mail: fos1@
aol.com). by Cajal Retzius cells in the marginal zone (Rice et al.,
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1998; Trommsdorff et al., 1999). In the embryonic cere-
bellum, VLDLR and ApoER2 are present in a differentiat-
ing field that contains Purkinje cell precursors (Tromms-
dorff et al., 1999). Early in cerebellar development,
Purkinje cells expressing Dab1 align in a distinct layer
beneath the external germinal layer that secretes Reelin
(Rice et al., 1998; Trommsdorff et al., 1999).
Several members of the LDLR family, including VLDLR
and ApoER2, have been shown to bind in vitro to the
protein interaction/phosphotyrosine binding (PI/PTB)
domain of Dab1 (Trommsdorff et al., 1998, 1999). The
cytoplasmic domain of the receptors that binds to Dab1
contains an NPxY motif, an amino acid region that is
required for receptor internalization (Chen et al., 1990).
Figure 1. Reelin Binds to Lipoprotein ReceptorsInterestingly, Dab1 also binds to an NPxY motif present
(A) Reelin expression in transfected 293T cells and brain extracts.in amyloid precursor protein (APP) family members, in-
293T cells were transfected with or without the Reelin expressioncluding the amyloid precursor-like protein 1 (APLP1), a
construct pCrl. Ten microliters of conditioned medium from trans-transmembrane protein that is prevalent in the brain
fected cells and 10 mg of a protein extract obtained from postnatal
(Trommsdorff et al., 1998; Homayouni et al., 1999; How- mouse brain were analyzed by SDS-PAGE on a 4%±12% gel. Reelin
ell et al., 1999b). However, mice in which APP family was detected by Western blotting using the N-terminal monoclonal
genes have been disrupted do not display ataxia or antibodies G10 and E4. Three isoforms of Reelin were detected,
a full-length protein of approximately 400 kDa and two truncatedcortical lamination defects similar to those in reelin-,
proteins of approximately 250 and 180 kDa.dab1-, and VLDLR/APOER2-deficient mice. The pheno-
(B) Reelin binds to cells expressing lipoprotein receptors. 293T cellstype of VLDLR2/2ApoER22/2 mice, together with the as-
were transfected with expression constructs containing VLDLR,
sociation of Dab1 with these receptors, implies that ApoER2, LDLR, or APLP1 or with no DNA (mock). The binding assay
these lipoprotein receptors function in a Reelin-depen- was conducted at 48C using approximately 106 transfected cells in
dent signaling pathway. Several mechanisms of action the presence of 1 mg/ml Reelin. Bound Reelin was detected by
Western blot analysis of cell extracts. Twenty-five percent of thecan be envisaged. For example, the lipoprotein recep-
cell lysate containing bound Reelin and 10% of the input Reelintors may bind Dab1 and bring it into the proximity of
supernatant were analyzed.cell surface receptors for Reelin. Alternatively, Reelin
may bind VLDLR or ApoER2 directly to exert its function
on migrating neurons. To distinguish between these 1999). To determine if Reelin binds to lipoprotein recep-
possibilities, we investigated the interaction of Reelin tors, 293T cells were transfected with expression con-
with lipoprotein receptors. structs encoding full-length VLDLR, ApoER2, and LDLR
cDNA. As controls, we used mock transfected cells and
cells transfected with an expression construct encoding
Results APLP1, a Dab1-binding transmembrane protein. Cells
were incubated in the presence of Reelin for 1 hr at 48C,
Reelin Binds to VLDLR and ApoER2 washed, and analyzed for their ability to retain Reelin
Reelin is a large protein of approximately 400 kDa that by Western blotting. All three Reelin isoforms were found
is relatively nonabundant. It has proven difficult to purify to associate with 293T cells expressing VLDLR and
Reelin from brain extracts or to produce it in heterolo- ApoER2, and to a lower extent with cells expressing
gous systems. To obtain a source of Reelin for our stud- LDLR. In contrast, no binding was detected using mock
ies, we transfected 293T cells transiently with a full- transfected cells or cells expressing APLP1 (Figure 1B).
length reelin cDNA clone, pCrl (D'Arcangelo et al., 1997). Under the conditions employed in this assay, in which
Reelin secreted from 293T cells was allowed to accumu- an excess of receptor was used, cells expressing either
late in the culture medium for a period of 2 days. Under VLDLR or ApoER2 bound approximately 26% of the total
the conditions used, we routinely obtain approximately applied Reelin, whereas cells expressing LDLR bound
1 mg/ml Reelin as determined by Coomassie blue stain- approximately 8% of Reelin present in the medium. Al-
ing in the conditioned medium (2.5 nM). Consistent with though all of the Reelin isoforms were capable of associ-
previous findings (Lambert de Rouvroit et al., 1999), we ating with lipoprotein receptors, full-length Reelin bound
identified three isoforms of approximately 400, 250, and more efficiently than the truncated proteins. Quantita-
180 kDa in conditioned medium from transfected cells tion of the amount of bound Reelin revealed that 32%
using antibodies directed against the N-terminal region of full-length, 17% of the 250 kDa, and 9% of the 180
of Reelin (de Bergeyck et al., 1998) (Figure 1A). Although kDa form of Reelin associated with cells expressing
the ratio of full-length to truncated proteins varied some- VLDLR and ApoER2 during the course of the experiment
what, all three isoforms were present in brain extracts (Figure 1B). Similar values were obtained when the ex-
(Figure 1A). It is likely that the truncated Reelin fragments periments were performed at room temperature (Fig-
are generated by the activity of a protease present in ure 2).
the post-Golgi secretory pathway or by an extracellular Analysis of the time course of the Reelin-VLDLR inter-
protease since they are not present in extracts of cells action indicated that Reelin binding was extremely rapid,
expressing mutated Reelin that cannot be secreted or as approximately 16% of Reelin present in the medium
associated with the receptor within 5 min of incubationin brefeldin-treated cells (Lambert de Rouvroit et al.,
Reelin Binds to VLDLR and ApoER2
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Figure 2. Time Course of Reelin Binding to
VLDLR
Binding assays were conducted at room tem-
perature using approximately 106 VLDLR-
transfected 293T cells and 1 mg/ml Reelin
for the indicated times. (A) Cell extracts were
examined by Western blotting analysis using
antibodies against Reelin (top panel). Twenty-
five percent of the cell lysate containing
bound Reelin and 10% of the input Reelin
supernatant were analyzed. The same filter
was reprobed with a polyclonal antiserum di-
rected against VLDLR (bottom panel). (B) The
percentage of bound Reelin was plotted
against the time of incubation. Numerical val-
ues were obtained from the blot shown in (A).
Binding approached saturation within 1 hr.
under the experimental conditions used (Figure 2). Simi- of 115 mg/ml of CR-50 antibody led to a 64% inhibition
lar levels of binding were detected when the binding in Reelin binding, whereas inhibition increased to 84%
assay was performed at 48C (data not shown). Reelin when a concentration of 300 mg/ml of CR-50 was used
continued to accumulate on VLDLR-expressing cells (Figure 3). Although the CR-50 and the G10 epitopes lie
over a 2 hr incubation period at room temperature, al- close to each other in the N terminus of Reelin, only CR-
though the binding approached equilibrium within 1 hr 50 has been shown to block Reelin function in vitro and
(Figure 2). To confirm that similar amounts of receptors in vivo (Ogawa et al., 1995; Del Rio et al., 1997; Miyata
were used at each time point, the filter was incubated et al., 1997; Nakajima et al., 1997). This implies that the
with an anti-VLDLR antibody (Figure 2A). Similar levels interaction between Reelin and VLDLR is functionally
of two proteins of approximately 130 and 150 kDa were significant.
detected in all VLDLR-transfected cells (Figure 2A). Because a purified preparation of Reelin of known
These bands were absent in mock transfected cells or concentration and activity is not currently available, it
in cells transfected with other lipoprotein receptors indi- is not possible to measure the affinity of Reelin for lipo-
cating that the antibody is specific for VLDLR (data not
protein receptors accurately. However, we were able to
shown). The two isoforms of VLDLR may arise from
estimate its apparent affinity by conducting quantitativematuration of a precursor protein or by alternative splic-
binding assays using a limiting amount of VLDLR-trans-ing (Iijima et al., 1998).
fected cells. Under these conditions, the addition ofThe association of Reelin with VLDLR was significantly
conditioned medium containing approximately 1 mg/mlreduced by the anti-Reelin neutralizing monoclonal anti-
Reelin (2.5 nM) was sufficient to saturate the receptorsbody CR-50, which recognizes an epitope located within
(Figure 4). Reelin binding to the VLDLR was modest atReelin amino acids 250±407 (Ogawa et al., 1995; D'Arc-
a concentration range of 0.08 to 0.31 nM, but it increasedangelo et al., 1997). In contrast, no inhibition was ob-
dramatically at concentrations above 0.31 nM. Underserved in the presence of the G10 monoclonal antibody
the conditions used, half-maximum binding occurred atthat recognizes a region located within Reelin amino
0.7 nM in two independent experiments (Figure 4B). Thisacids 164±245 (de Bergeyck et al., 1998), or in the pres-
indicates that VLDLR is a high-affinity receptor forence of normal mouse IgG (Figure 3). The level of inhibi-
Reelin. This apparent affinity is comparable to that oftion of Reelin binding was dependent on the concentra-
tion of CR-50 antibody used in the experiment. Addition the 39 kDa receptor-associated protein (RAP), which
Figure 3. The Neutralizing Antibody CR-50
Inhibits Binding of Reelin to VLDLR
293T cells were transfected with VLDLR, and
Reelin binding assays were carried out for 1
hr at room temperature using approximately
106 transfected cells. (A) Transfected cells
were incubated with 0.4 mg/ml Reelin and 300
mg/ml of the anti-Reelin monoclonal antibod-
ies CR-50 and G10 or mouse IgG as a control.
Bound Reelin was detected by Western blot
analysis of cell extracts.
(B) Histogram of Reelin binding to VLDLR in
two independent experiments. Transfected
cells were incubated with 0.8 mg/ml Reelin
and 115 mg/ml of CR-50 or mouse IgG or with
0.4 mg/ml Reelin and 300 mg/ml antibodies or
mouse IgG as described in (A).
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Figure 4. Reelin Binds to VLDLR with High
Affinity
(A) Binding assays were conducted at 48C
for 1 hr using a limiting amount of VLDLR-
transfected 293T cells (approximately 105
cells) and conditioned medium containing the
indicated concentrations of Reelin. For con-
centrations below 2.5 nM, the Reelin-con-
taining medium was diluted consecutively
2-fold with medium conditioned by mock
transfected cells. Bound Reelin was detected
by Western blot analysis of cell extracts.
(B) The relative amount of Reelin bound to
VLDLR-expressing cells from two indepen-
dent experiments was plotted against the
concentration of Reelin (nM). The amount of
Reelin bound at the 2.5 nM concentration represents 100% binding. In one experiment (circles), numerical values were obtained from the blot
in (A). In another experiment (diamonds), binding was conducted at 48C for 3 hr using a limiting amount of VLDLR-transfected 293T cells
(approximately 105 cells). We determined that Reelin was not depleted from the conditioned medium during the course of the experiments
by dot blot analysis.
has been shown to bind VLDLR with high affinity (Battey apoE Inhibits the Interaction of Reelin with VLDLR
and ApoER2et al., 1994).
apoE is a major constituent of very low-density lipopro-
teins, and it binds to all members of the LDLR familyReelin Is Internalized by Cells Expressing VLDLR
(Mahley, 1988). Three major isoforms, apoE2, apoE3,Lipoprotein receptors internalize many extracellular li-
and apoE4, are encoded by different alleles of humangands through a mechanism involving their cytoplasmic
APOE. Therefore, we investigated the effect of apoE-NPxY motifs (Chen et al., 1990). We used an immunocy-
containing lipoproteins and recombinant apoE isoformstochemical approach to determine whether Reelin is
on the interaction of Reelin with VLDLR and ApoER2.internalized following association with VLDLR. COS-7
Recombinant apoE3, the most common isoform ofcells expressing VLDLR were incubated with Reelin for
apoE, significantly inhibited the binding of Reelin to both15 min at 378C, and Reelin and VLDLR were visualized
VLDLR and ApoER2 (Figure 6A). apoE3 reduced theby immunocytochemistry. Consistent with the binding
binding of 1 mg/ml Reelin to ApoER2 by approximatelyassays described above using 293T cells, Reelin associ-
50%. Comparison of the effects of purified apoE-VLDLated only with COS-7 cells that expressed VLDLR (Fig-
and recombinant apoE isoforms indicated that apoE3ures 5A±5C). In nonpermeabilized cells, Reelin was dis-
and apoE4 consistently inhibited Reelin binding totributed across the surface of cells expressing VLDLR
VLDLR more efficiently than apoE2 or apoE-VLDL in(Figures 5D and 5E). An additional population of Reelin
several experiments. In a typical experiment (Figure 6A),molecules was revealed after permeabilization of the
apoE3 and apoE4 inhibited Reelin binding to VLDLR bysame cells by treatment with detergent (Figure 5F). This
approximately 60%, whereas the level of inhibition bypopulation of Reelin was relatively minor, and it ap-
apoE2 was approximately 10%. This is consistent withpeared to be associated with large vesicular structures
previous studies indicating that apoE2 binds LDLR less(Figures 5F and 5I). No internalized Reelin was detected
efficiently than apoE3 and apoE4 (Weisgraber et al.,when VLDLR-transfected cells were incubated with
1982). Interestingly, only a modest inhibition of ReelinReelin at 48C (Figures 5J±5L). These results indicate that
binding was observed in the presence of apoE-VLDL,the association of Reelin with VLDLR results in internal-
raising the possibility that VLDLR may interact preferen-
ization of Reelin.
tially with apoE3 and apoE4 proteins rather than lipopro-
tein particles or that apoE proteins may bind to Reelin
Reelin Binding to Lipoprotein Receptors directly.
Is Calcium Dependent Previously, it was demonstrated that addition of Reelin
The ligand binding domains of LDLR family members to primary neurons causes phosphorylation of Dab1 on
contain disulphide bridges as well as calcium-binding tyrosine residues (Howell et al., 1999a). To determine
residues (Fass et al., 1997). Binding of lipoprotein to whether apoE inhibits Reelin signaling in neurons, we
LDLR is absolutely dependent on the presence of extra- conducted several experiments by treating dissociated
cellular calcium (van Driel et al., 1987). To investigate embryonic cortical neurons with Reelin in the presence
whether the association of Reelin with VLDLR and or absence of apoE3. In a typical experiment (Figure
ApoER2 is also calcium dependent, we treated VLDLR- 6B), addition of Reelin alone to dissociated neurons
and ApoER2-transfected cells with Reelin in the pres- caused a 3-fold increase in the levels of tyrosine phos-
ence and absence of 1 mM EGTA. The addition of this phorylation of Dab1. Addition of 50 mg/ml apoE3 re-
chelating agent completely abolished binding of Reelin duced the Reelin-induced increase in tyrosine phos-
to VLDLR and ApoER2 (Figure 6A). This effect was abro- phorylation by approximately 50%. apoE3 alone also
gated by addition of 3 mM calcium, and similar results caused a slight decrease in the basal level of tyrosine
phosphorylation of Dab1 (10%). These data suggest thatwere obtained using 1 mM EDTA (data not shown).
Reelin Binds to VLDLR and ApoER2
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Figure 5. Cells Expressing VLDLR Internalize
Reelin
COS-7 cells were transfected with a VLDLR
expression construct and treated with Reelin-
containing conditioned medium for 15 min at
378C. Cells were then fixed and permeabil-
ized, except in (D). VLDLR was detected using
a rabbit polyclonal antibody directed against
the intracellular domain. Reelin was detected
using the mouse monoclonal antibody E4.
(A-C) Comparison of Reelin binding and
VLDLR expression in transfected cells. (A)
Transfected cells visualized by phase con-
trast. (B) VLDLR-expressing cells were identi-
fied using FITC-conjugated anti-rabbit anti-
bodies (green). (C) Reelin bound to the cells
was visualized using Texas Red-conjugated
anti-mouse antibodies (red). Only cells that
expressed VLDLR were positive for Reelin.
(D±F) Sequential staining was performed to
demonstrate internalization of Reelin. (D)
Nonpermeabilized cell expressing Reelin on
the cell surface visualized as described in (C).
Following permeabilization by treatment with
detergent, the same cell was stained for
VLDLR (E) and once more for Reelin to detect
the intracellular protein (F). Reelin appears to
be localized to large intracellular vesicles.
(G-L) Transfected cells were incubated with
Reelin in parallel at room temperature (G-I) or
at 48C (J-L). Cells were fixed and perme-
abilized before incubating with antibodies
against VDLDR and Reelin. VLDLR was visu-
alized with an AMCA-conjugated anti-rabbit
antibody (blue, [H] and [K]). Reelin was visual-
ized with a FITC-conjugated anti-mouse anti-
body (green, [I] and [L]).
apoE3 interferes with the ability of Reelin to activate a (Figure 7). The apparent affinity of Reelin for VLDLR is
similar to that of RAP, a well-known ligand for lipoproteinDab1-dependent signaling pathway in neurons.
receptors. However, RAP is an intracellular chaperone
and not a physiological extracellular ligand (Willnow et
al., 1996). The high affinity of Reelin for these receptorsDiscussion
suggests that Reelin may be a natural ligand for VLDLR
and ApoER2 in the brain. The interaction of Reelin withA Model for Reelin Function in Brain Development
The data presented here indicate that Reelin functions VLDLR results in internalization of Reelin, a phenomenon
that is well documented for all the extracellular ligandsby binding to the lipoprotein receptors, VLDLR and
ApoER2, to direct cell positioning in the developing brain of LDLR family members (Brown and Goldstein, 1986;
Figure 6. Inhibition of Reelin Binding to
VLDLR- and ApoER2-Expressing 293T Cells
by EGTA and apoE Isoforms
(A) 293T cells were transfected with VLDLR,
ApoER2, or with no DNA (mock). Approxi-
mately 106 transfected cells were incubated
at 48C with 1 mg/ml Reelin alone (-) or in the
presence of 1 mM EGTA, 25 mg/ml of the
indicated recombinant apoE isoforms, apoE2,
apoE3, and apoE4, or purified apoE-VLDL
(VLDL). Bound Reelin was detected by West-
ern blot analysis of cell extracts.
(B) Reelin-induced tyrosine phosphorylation
of Dab1 is inhibited by apoE. Cortical neurons
obtained from embryonic day 16.5 mice were
incubated with 1 mg/ml Reelin in the presence
or absence of 50 mg/ml recombinant apoE3. Dab1 was immunoprecipitated using polyclonal antibodies and subjected to Western blot analysis
Neuron
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a consequence of its ability to block binding of Reelin
to lipoprotein receptors.
We did not find any evidence for a coreceptor mole-
cule in our binding studies since Reelin did not associate
with 293T or COS cells in the absence of transfected
lipoprotein receptors. Furthermore, if another trans-
membrane protein was required for Reelin binding to
lipoprotein receptors, it would have to be a highly ex-
pressed and relatively ubiquitous protein, as we were
able to demonstrate very high levels of Reelin binding
to the transfected cells. Although we cannot formally
rule out the possibility that other cell surface molecules
participate in Reelin signal transduction, the simplest
interpretation of our data is that VLDLR and ApoER2
function as receptors for Reelin.
VLDLR and ApoER2 are transmembrane proteins that
do not contain intrinsic tyrosine kinase activity. ThisFigure 7. A Model for Reelin Signaling
indicates that Reelin induces Dab1 tyrosine phosphory-
Extracellular Reelin binds lipoprotein receptors of the LDLR family,
lation by recruiting an as yet unidentified protein kinase.and it is internalized. Binding of Reelin to lipoprotein receptors is
Mammalian Dab1 can be phosphorylated in vitro by Abl,inhibited by the presence of apoE. Dab1 associates with the cyto-
Src, Fyn, Lyn, and Arg (Howell et al., 1997a; data notplasmic domain of lipoprotein receptors. Internalization of the
Reelin-lipoprotein receptor complexes into endocytic vesicles re- shown). Thus, it is possible that members of the nonre-
sults in increased tyrosine phosphorylation of Dab1 by recruitment ceptor tyrosine kinase family phosphorylate Dab1 in re-
of an unidentified kinase(s) and in increased turnover of Dab1. Dab1 sponse to Reelin. However, tyrosine phosphorylation of
also associates with other transmembrane proteins including APP
Dab1 is undiminished in brain extracts derived from micefamily members. Reelin-induced modification of Dab1 phosphoryla-
lacking Src, Abl, or Fyn (Howell et al., 1997a). In addition,tion may represent a critical step in the transmission of a Reelin
recently we identified a tyrosine kinase activity that as-signal from the extracellular environment to intracellular events such
as second messenger activation and altered gene expression. sociates with Dab1 (our unpublished data). This activity
Through these events, Reelin directs the formation of cortical layers is present in brain extracts from mice lacking Abl, Fyn,
during brain development. The Reelin signaling pathway may also Lyn, Lck, Src, or Yes. Thus, at the present time, it is not
contribute to events associated with neuronal regeneration or de-
clear whether none of these tyrosine kinases phosphory-generation in the adult brain.
late Dab1 in vivo or whether they have overlapping func-
tions.
Gliemann, 1998). Since Dab1 binds to an intracellular
domain of lipoprotein receptors, internalization of the Role of the Reelin Pathway in the Adult Brain
Reelin is expressed at high levels in postnatal brain,Reelin-lipoprotein receptor complex may also cause en-
docytosis and subsequent degradation of Dab1. This long after neuronal migration is complete (Ikeda and
Terashima, 1997; Alcantara et al., 1998). Sites of highcould explain previous observations that Dab1 accumu-
lates in ectopic neurons in mice lacking Reelin or VLDLR expression include the hippocampus, the entorhinal cor-
tex, the olfactory bulb, and the cerebellum. Thus, thereand ApoER2 (Rice et al., 1998; Trommsdorff et al., 1999).
The induction of tyrosine phosphorylation of Dab1 by is a correlation between high levels of Reelin expression
and the requirement for the maturation of neuronal pro-Reelin has been shown to depend on the presence of
divalent cations (Howell et al., 1999a). Here, we demon- cesses and synaptic remodeling. A role for Reelin in
synaptogenesis and axonal branching has already beenstrate that the interaction of Reelin with VLDLR and
ApoER2 requires calcium (Figure 6A). Similarly, the li- suggested in the postnatal hippocampus (Del Rio et al.,
1997; Borrell et al., 1999). VLDLR, ApoER2, and Dab1gand binding domains of LDLR require calcium in order
to bind lipoproteins (van Driel et al., 1987). Taken to- are also expressed in the postnatal brain (Kim et al.,
1996; Rice et al., 1998). Thus, it is conceivable that thegether, these observations suggest that Reelin may bind
to the ligand binding domains of VLDLR and ApoER2. components of the Reelin pathway that participate in
the termination of neuronal migration in the embryonicThe interaction of Reelin with VLDLR is also inhibited
by the CR-50 antibody, which recognizes an epitope brain may also be involved in the growth and remodeling
of neuronal processes in the adult brain.present in the N-terminal region of Reelin. The CR-50
epitope appears to represent a three-dimensional struc- Here, we show that binding of Reelin to VLDLR and
ApoER2 is inhibited by apoE. The APOE gene is ex-ture as it is destroyed by fixation or denaturation, and
it maps to a region of greater than 100 amino acids. The pressed at high levels throughout the brain, where it is
thought to function in phospholipid homeostasis as wellimportance of this structure is underscored by the fact
that CR-50 inhibits cortical layer formation in rotating as growth factor modulation by interacting with LRP
(Gutman et al., 1997). apoE also accumulates to verycultures (Ogawa et al., 1995), formation of the Purkinje
cell layer in cerebellar explants (Miyata et al., 1997), and high levels in response to neuronal injury in the central
and peripheral nervous systems (Skene and Shooter,axonal branching of entorhino-hippocampal fibers (Del
Rio et al., 1997), and disrupts formation of the hippocam- 1983; Poirier et al., 1991). Furthermore, epidemiological
studies have shown that the apoE4 allele is a susceptibil-pus in vivo (Nakajima et al., 1997). Based on our findings,
it now appears that the inhibitory effects of CR-50 are ity factor for Alzheimer's disease (Strittmatter and
Reelin Binds to VLDLR and ApoER2
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Roses, 1995). The ability of apoE isoforms to interfere lipoprotein receptors or bind to Reelin. Further studies
will be necessary to elucidate the mechanism wherebywith Reelin binding to VLDLR correlates with their re-
spective affinities for the ligand binding domains of lipo- apoE inhibits the interaction of Reelin with lipoprotein
receptors.protein receptors. This observation raises the intriguing
possibility that Reelin may contribute to some of the VLDLR and ApoER2 display an overall modular struc-
ture similar to that of the LDLR (Gliemann, 1998; Willnow,complex processes involved in neurodegeneration.
In addition to the effect of apoE on Reelin signaling 1999). These receptors contain ligand binding repeat
regions similar to those of complement type A and re-described above, several other pieces of circumstantial
evidence link the Reelin pathway to neuropathology. gions of similarity with the epidermal growth factor (EGF)
precursor, including six cysteine repeat motifs. VLDLRThe PI/PTB domain of Dab1 has been shown to bind to
the NPxY motif present in the cytoplasmic domain APP and at least one isoform of ApoER2 contain eight ligand
binding repeats, one more than LDLR. Despite thesefamily members (Trommsdorff et al., 1998; Homayouni
et al., 1999; Howell et al., 1999b). A proteolytic product structural similarities, several studies suggest that the
ligand binding specificities and the physiological rolesof APP, APPb, is a major constituent of the amyloid
plaques that are characteristic of Alzheimer's disease. of VLDLR and ApoER2 may differ from those of the
LDLR (Kim et al., 1996; Nimpf and Schneider, 1998).Furthermore, mutations in APP have been linked to au-
tosomal dominant familial Alzheimer disease, the most First, VLDLR and ApoER2 are expressed in several tis-
sues, including the brain, but not in liver, whereas LDLRcommon form of late-onset dementia (Price and Sisodia,
1998). Mice lacking the cyclin-dependent kinase 5 (cdk5) is expressed predominantly in the liver. Second, unlike
LDLR, VLDLR and ApoER2 do not bind to low-densityor its activating subunit p35 display an abnormality in
cortical lamination that is similar but not identical to that lipoprotein particles. Third, very low-density lipoprotein
particles bind to LDLR with a higher affinity than toobserved in reeler mice (Ohshima et al., 1996; Chae et
al., 1997). Therefore, it is conceivable that cdk5 activity VLDLR. The modest role played by VLDLR in lipoprotein
metabolism is also emphasized by the fact that themay be involved in downstream signaling events acti-
vated by Reelin. Interestingly, Cdk5 immunoreactivity plasma lipoprotein profile is unaffected in mice lacking
VLDLR (Frykman et al., 1995). Taken together, theseincreases in neurons that exhibit early stage neurofibril-
lary tangles, a hallmark of Alzheimer's disease, and cdk5 findings suggested that VLDLR does not function pri-
marily as a receptor for lipoproteins. The results pre-can phosphorylate tau, a microtubule-associated pro-
tein that accumulates in a hyperphosphorylated form in sented here suggest that Reelin may be a physiological
ligand for VLDLR and ApoER2 in the developing, andneurofibrillary tangles (Imahori and Uchida, 1997). Cdk5
can also phosphorylate Dab1 efficiently in vitro on serine perhaps in the adult, brain.
and threonine residues (our unpublished data). These
findings raise the possibility that Dab1 may play a role
Experimental Proceduresin physiological and pathophysiological processes in-
volving APP. While none of these observations provides Plasmid Constructs
compelling evidence that the Reelin pathway is involved The following mammalian expression constructs were used: pCrl
in Alzheimer's disease, collectively they suggest that it (D'Arcangelo et al., 1997), encoding mouse reelin cDNA, a construct
containing the human VLDLR, a construct containing a brain splicemay be interesting to explore the relationship between
variant of the mouse ApoER2 cDNA (Brandes et al., 1997), pLDLR-the molecular mechanisms that regulate cell migration
17 (Russell et al., 1989), containing the human LDLR cDNA, and aduring brain development and neurodegenerative pro-
construct encoding mouse APLP1 cDNA (Homayouni et al., 1999).
cesses.
AntibodiesLipoprotein Receptors in Brain Development
The anti-Reelin mouse monoclonal antibody G10 (de Bergeyck et
The unexpected role of lipoprotein receptors in brain al., 1998) was obtained as ascites fluids. The anti-Reelin mouse
development was revealed recently by the finding that monoclonal antibodies E4 (de Bergeyck et al., 1998) and CR-50
VLDLR and ApoER2 double knockout mice resemble (Ogawa et al., 1995) were Protein A purified from hybridoma cell
culture supernatants. The rabbit anti-VLDLR polyclonal antibody,Reelin- and Dab1-deficient mice (Trommsdorff et al.,
raised against the C-terminal region of human VLDLR, was obtained1999). Mice lacking one of the receptor genes display
as whole serum. Purified mouse IgG was purchased from Jacksononly a modest phenotype, indicating that these two re-
Laboratories. Secondary antibodies used for immunofluorescence
ceptors may have overlapping functions. Our observa- were FITC-conjugated anti-rabbit IgG (Jackson Laboratories), Texas
tion that Reelin binds equally well to VLDLR and ApoER2 Red-conjugated anti-mouse IgG (Molecular Probes), and AMCA-
is consistent with this view. VLDLR and ApoER2 selec- conjugated anti-rabbit IgG (Molecular Probes). The secondary anti-
bodies used for Western blot analysis were HRP-conjugated anti-tively bind apoE-containing lipoproteins, whereas LDLR
mouse or anti-rabbit IgG (Amersham). Polyclonal goat anti-Dab1binds apoE- and apoB-100-containing lipoproteins. It
antibodies used for immunoprecipitation were affinity purified. HRP-has been previously shown that, in order to bind LDLR
conjugated 4G10 anti-phosphotyrosine antibody (Pierce) was used
with high affinity, apoE must be complexed with lipids to detect phosphorylated Dab1.
(Innerarity et al., 1979). Here, we demonstrate that re-
combinant apoE proteins are more effective than apoE-
Cell Culture and Transfectioncontaining VLDL at inhibiting Reelin binding to VLDLR
293T and COS-7 cells were obtained from ATCC. Cells were culturedand that recombinant apoE3 can interfere with phos-
in Dulbecco's modified Eagle medium (BioWhitaker) supplemented
phorylation of Dab1 in dissociated neurons. These find- with 10% fetal bovine serum (Life Technologies), 10 U/ml penicillin/
ings suggest that, at the concentrations used in our streptomycin mixture (Life Technologies), and 2 mM GlutaMAX (Life
Technologies) at 378C under 5% CO2. Cells were transfected withstudy, recombinant apoE may either be able to modulate
Neuron
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plasmid constructs using the Fugene6 transfection reagent (Boeh- mg/ml stock. Subsequently, the cells were permeabilized with 0.1%
Triton X-100 in PBS, blocked in 2.5% horse serum, and reincubatedringer Mannheim) according to the manufacturer instructions. Corti-
cal neurons were dissociated from embryonic day 16.5 mice derived with the E4 antibody and with anti-VLDLR antiserum used at a 1:1000
dilution. Secondary antibodies were used at a 1:1000 dilution.from the mating of two reeler heterozygotes (obtained from The
Jackson Laboratory). Cerebral cortical neurons from ten embryos
were dissociated in ice-cold Hank's Balanced Salt Solution, pooled, Dab1 Phosphorylation Analysis
and triturated in serum free Dulbecco's modified Eagle medium. Dissociated neuronal cultures were treated in suspension with or
without Reelin-containing medium. Cells were lysed in a buffer con-
taining 50 mM Tris, 1% NP-40, 150 mM NaCl, 5 mM EDTA, 1 mMReelin Expression
Na vanadate, 10 mg/ml leupeptin, and 10 mg/ml aprotinin. After293T cells were transfected with the full-length mouse Reelin ex-
clarifying the extracts, Dab1 was immunoprecipitated and analyzedpression construct pCrl. The following day, the culture medium was
by Western blotting as described above. Quantitative analysis ofreplaced with a serum-reduced medium (Nephrigen, Celox Labora-
Dab1 phosphorylation was performed by densitometry as describedtories). After 2 more days, the conditioned medium was collected
above for the Reelin binding studies.and stored at 48C. To calculate the amount of Reelin produced, the
conditioned medium from mock and Reelin-transfected cells was
concentrated 20-fold using Centricon 100 filters (Amicon) and ana- Acknowledgments
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